Intellectia LogoIntellectia
Product
Resources
Markets
News
Partner Program
Pricing
Log inTry for Free
Intellectia Logo
Log in
Intellectia Logo

Product

Features
Financial AI Agent
Stock Technical Analysis
Stock Monitor
Hedge Fund Tracker
AI Screener
Trading Strategies
AI Stock Picker
Swing Trading
Quant AI
Stock Chart Patterns
Daytrading Center
AI Earnings Prediction
Whales Auto Tracker
Backtesting Playground

Resources

Learn
Blog
Earnings
Tutorial
Help Center
Company
About Us
Contact
Press
Reward Program
Partner Program
Tools
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Compare
TradingView
SeekingAlpha

Markets

Trending Stocks
Hot Crypto
Trending News
All Stocks

News

Trading News
Overview
Top News
Daily Market Brief
Earnings
Latest
Newswire
Stock News
Crypto News
Monitor News
Partner ProgramPricing
Start for Free
  1. Home
    2. >
  2. Stock
    3. >
  3. UHS
stocks logo

UHS

-
collectAdd to Watchlistadvanced chartAdvanced Chart
$
0.000
0(0.000%)1D
collectadvanced chart
    Overview
    Forecast
    Valuation
    Earnings
High
--
Open
--
VWAP
--
Vol
--
Mkt Cap
--
Low
--
Amount
--
EV/EBITDA(TTM)
--
Total Shares
--
EV
--
EV/OCF(TTM)
--
P/S(TTM)
--
Financial AI Agent
Financial AI Agent

Market Estimates

Earnings Estimates
Earnings Estimates
Revenue
YoY Chg
EPS
YoYChg
FY2025Q4
FY2026Q1
FY2026Q2
4.50B
+9.48%
5.891
+19.73%
4.34B
+5.92%
5.322
+9.96%
4.50B
+5.08%
5.874
+9.79%
Estimates Revision
The market is revising Upward the revenue expectations for Universal Health Services, Inc. (UHS) for FY2025, with the revenue forecasts being adjusted by 1.13% over the past three months. During the same period, the stock price has changed by 24.19%.
Revenue Estimates for FY2025
Revise Upward
up Image
+1.13%
In Past 3 Month
EPS Estimates for FY2025
Revise Upward
up Image
+5.51%
In Past 3 Month
Stock Price
Go Up
up Image
+24.19%
In Past 3 Month
Wall Street analysts forecast UHS stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for UHS is 249.31 USD with a low forecast of 190.00 USD and a high forecast of 302.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
15 Analyst Rating
Wall Street analysts forecast UHS stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for UHS is 249.31 USD with a low forecast of 190.00 USD and a high forecast of 302.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
8 Buy
6 Hold
1 Sell
Moderate Buy
Current: 230.590
sliders
Low
190.00
Averages
249.31
High
302.00
Current: 230.590
sliders
Low
190.00
Averages
249.31
High
302.00
Guggenheim
Jason Cassorla
Buy
upgrade
$253 -> $274
2025-12-02
New
Reason
Guggenheim
Jason Cassorla
Price Target
$253 -> $274
2025-12-02
New
upgrade
Buy
Reason
Guggenheim analyst Jason Cassorla raised the firm's price target on Universal Health to $274 from $253 and keeps a Buy rating on the shares.
Wells Fargo
Stephen Baxter
Overweight
maintain
$249 -> $259
2025-11-13
Reason
Wells Fargo
Stephen Baxter
Price Target
$249 -> $259
2025-11-13
maintain
Overweight
Reason
Wells Fargo analyst Stephen Baxter raised the firm's price target on Universal Health to $259 from $249 and keeps an Overweight rating on the shares following quarterly results. Overall, modestly higher EBITDA estimates and rolling fully to 2027 estimates offsets a material increase in the odds of enhanced exchange subsidies expiring in the firm's price target framework, Wells says.
Mizuho
Outperform
maintain
$242 -> $267
2025-11-03
Reason
Mizuho
Price Target
$242 -> $267
2025-11-03
maintain
Outperform
Reason
Mizuho raised the firm's price target on Universal Health to $267 from $242 and keeps an Outperform rating on the shares. The company reported strong Q3 results and continues to benefit from solid underlying demand trends, the analyst tells investors in a research note.
Raymond James
Market Perform
to
Outperform
upgrade
$270
2025-11-03
Reason
Raymond James
Price Target
$270
2025-11-03
upgrade
Market Perform
to
Outperform
Reason
Raymond James upgraded Universal Health to Outperform from Market Perform with a $270 price target. The company's Q3 results were above guidance and consensus forecasts, showing improved execution, the analyst tells investors in a research note. The firm says Universal Health also faces easy comparisons for 2026 while the shares trade at an attractive valuation.
RBC Capital
Sector Perform
maintain
$206 -> $231
2025-10-30
Reason
RBC Capital
Price Target
$206 -> $231
2025-10-30
maintain
Sector Perform
Reason
RBC Capital raised the firm's price target on Universal Health to $231 from $206 and keeps a Sector Perform rating on the shares. The company reported a headline beat and its behavioral volumes showed modest improvement, though remain below the management's internal targets, the analyst tells investors in a research note. RBC adds it is encouraged by the management's sizing of the potential impact of the enhanced exchange subsidies expiration.
UBS
AJ Rice
Buy
maintain
$280 -> $302
2025-10-29
Reason
UBS
AJ Rice
Price Target
$280 -> $302
2025-10-29
maintain
Buy
Reason
UBS analyst AJ Rice raised the firm's price target on Universal Health to $302 from $280 and keeps a Buy rating on the shares.
See All Ratings

Valuation Metrics

The current forward P/E ratio for Universal Health Services Inc (UHS.N) is 10.03, compared to its 5-year average forward P/E of 11.69. For a more detailed relative valuation and DCF analysis to assess Universal Health Services Inc 's fair value, click here.
  • Forward PE
  • Forward EV/EBITDA
  • Forward PS

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
Fair
5Y Average PE
11.69
Current PE
10.03
Overvalued PE
13.59
Undervalued PE
9.79

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average EV/EBITDA
7.98
Current EV/EBITDA
0.00
Overvalued EV/EBITDA
8.85
Undervalued EV/EBITDA
7.12

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average PS
0.76
Current PS
0.00
Overvalued PS
0.90
Undervalued PS
0.62
AI Stock Picker
AI Stock Picker

Financials

Annual
Quarterly
N/A
Total Revenue
N/A
Operating Profit
N/A
Net Income after Tax
N/A
EPS - Diluted
N/A
Free Cash Flow
N/A
Gross Profit Margin - %
N/A
FCF Margin - %
N/A
Net Margin - %
N/A
ROIC

Trading Trends

  • Insider
  • Hedge Fund
  • Congress Trading
Insider
Insiders areSelling! The selling amount has increased 291.34% over the last month.
Sold
Bought
Hedge Fund
Hedge Funds are Neutral. There are no significant trading trends over the last quarter.
Sold
Bought
Congress Trading
Congress are Neutral. There are no significant trading trends over the last month.
Sold
Bought
Insider
Insiders areSelling! The selling amount has increased 291.34% over the last month.
Sold
Bought
Intellectia AI SwingMax
Intellectia AI SwingMax

UHS News & Events

Events Timeline

(ET)
2025-10-27
16:18:06
Universal Health increases FY25 adjusted EPS forecast to $21.50-$22.10, up from $20.00-$21.00
select
2025-10-27
16:16:37
Universal Health announces Q3 adjusted EPS of $5.69, surpassing consensus of $4.95
select
2025-10-27
14:12:53
Prominent Companies Set to Report After Market Close
select
Sign Up For More Events
Sign Up For More Events

News

[object Object]
Preview
7.0
01:30 AMBusinesswire
Scott+Scott Investigates UHS Board for Potential Breach of Fiduciary Duties
  • Legal Investigation Initiated: Scott+Scott Attorneys at Law LLP is investigating whether the board of Universal Health Services (UHS) breached their fiduciary duties to the company and its shareholders, potentially leading to shareholder losses.
  • Surge in Lawsuits: According to the Capitol Forum, over 30 lawsuits have been filed against UHS in 2025, alleging sexual abuse of minors at its for-profit psychiatric hospitals, which severely impacts the company's reputation.
  • Shareholder Rights at Risk: Shareholders of UHS may have legal claims against the directors and officers, indicating potential governance risks that could undermine shareholder confidence.
  • Legal Assistance Offered: Scott+Scott is providing legal consultation services to help shareholders understand their rights and explore possible legal actions, demonstrating a commitment to protecting shareholder interests.
[object Object]
Preview
5.0
12-04NASDAQ.COM
EHC Launches New Rehabilitation Hospital in Lake Worth to Address Growing Need

  • New Facility Opening: Encompass Health Corporation has opened the Encompass Health Rehabilitation Hospital of Lake Worth in Florida, featuring 50 beds and advanced rehabilitation technologies to assist patients recovering from complex medical issues.

  • Comprehensive Care Model: The hospital employs an interdisciplinary care model, providing tailored treatment plans that include a minimum of three hours of therapy five days a week, 24/7 nursing care, and physician oversight to enhance patient mobility and quality of life.

  • Expansion Plans: EHC is expanding its presence in Florida, marking its 26th location in the state, and plans to open seven new hospitals and add beds to existing facilities in 2025, reflecting the growing demand for rehabilitation services.

  • Financial Performance: EHC's net operating revenues increased by 10.6% year-over-year in the first nine months of 2025, with its stock gaining 23.3% year-to-date, outperforming the industry average growth of 10.3%.

[object Object]
Preview
3.0
12-03NASDAQ.COM
Top Growth Stocks to Consider Purchasing on December 3rd

  • Micron Technology, Inc.: This semiconductor company has a Zacks Rank #1, with a 7% increase in current year earnings estimates and a PEG ratio of 0.49, indicating strong growth potential.

  • Great Lakes Dredge & Dock Corporation: Also holding a Zacks Rank #1, this dredging services provider has seen a 7.8% rise in earnings estimates and a PEG ratio of 0.97, reflecting solid growth characteristics.

  • Universal Health Services, Inc.: This healthcare services company, with a Zacks Rank #1, has experienced a 6.8% increase in earnings estimates and a PEG ratio of 0.81, showcasing its growth potential.

  • Investment Insights: The article suggests that lesser-known AI firms may offer more lucrative investment opportunities compared to well-known stocks, encouraging investors to explore these options.

Sign Up For More News

People Also Watch

FAQ

arrow icon

What is Universal Health Services Inc (UHS) stock price today?

The current price of UHS is 230.59 USD — it has increased 0.19 % in the last trading day.

arrow icon

What is Universal Health Services Inc (UHS)'s business?

Universal Health Services, Inc. is a holding company. The Company operates, through its subsidiaries, including its management company. It is engaged in owning and operating acute care hospitals and outpatient facilities, and behavioral healthcare facilities. Its segments include acute care hospital services, behavioral health care services, and Other. It owns and operates approximately 359 inpatient facilities, and 60 outpatient and other facilities located in 39 states, Washington, D.C., the United Kingdom, and Puerto Rico. It provides services, which include general and specialty surgery, internal medicine, obstetrics, emergency room care, radiology, oncology, diagnostic care, coronary care, pediatric services, pharmacy services and/or behavioral health services. It also provides capital resources, as well as a variety of management services to its facilities, including information services, finance and control systems, physician recruitment services, and public relations.

arrow icon

What is the price predicton of UHS Stock?

Wall Street analysts forecast UHS stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for UHS is 249.31 USD with a low forecast of 190.00 USD and a high forecast of 302.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

arrow icon

What is Universal Health Services Inc (UHS)'s revenue for the last quarter?

Universal Health Services Inc revenue for the last quarter amounts to 4.50B USD, increased 13.43 % YoY.

arrow icon

What is Universal Health Services Inc (UHS)'s earnings per share (EPS) for the last quarter?

Universal Health Services Inc. EPS for the last quarter amounts to 5.86 USD, increased 54.21 % YoY.

arrow icon

What changes have occurred in the market's expectations for Universal Health Services Inc (UHS)'s fundamentals?

The market is revising Upward the revenue expectations for Universal Health Services, Inc. (UHS) for FY2025, with the revenue forecasts being adjusted by 1.13% over the past three months. During the same period, the stock price has changed by 24.19%.
arrow icon

How many employees does Universal Health Services Inc (UHS). have?

Universal Health Services Inc (UHS) has 86000 emplpoyees as of December 05 2025.

arrow icon

What is Universal Health Services Inc (UHS) market cap?

Today UHS has the market capitalization of 14.41B USD.

Intellectia LogoIntellectiaIntellectia LogoIntellectia

Redefine Your Investment Decisions

TwitterTwitterYoutubeYoutubeQuoraQuoraDiscordDiscordLinkedinLinkedinTelegramTelegram
AppStoreGooglePlay

Copyright © 2025 Intellectia.AI. All Rights Reserved.

pci certified logo
Company
HomeContactAbout UsNews Release
Compare
TradingViewSeeking Alpha
Features
Financial AI AgentStock Technical AnalysisStock MonitorHedge Fund TrackerAI ScreenerDaytrading Center
Strategies
AI Stock PickerSwing TradingStock Chart PatternsEarnings TradingDaytrading CenterAI Earnings PredictionQuant AIWhales Auto TrackerBacktesting Playground
Free Tools
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Resource
BlogTutorialEarningsTrending StocksCrypto MarketPartner ProgramTerms of UsePrivacy PolicySecuritySitemap
Start for Free